Broad Tab Private Limited is one of India’s leading pharma tablets manufacturers in India. The company specializes in the production and distribution of high-quality pharmaceutical tablets across various therapeutic segments. With state-of-the-art manufacturing facilities, Broad Tab ensures that all its products meet stringent regulatory standards and are :
Pharma Tablet Manufacturers in India
Pharmaceutical Tablets Manufacturers in India
Tablet Capsule Manufacturers in India.
Key Features:
1. High-Quality Manufacturing: Broad Tab adheres to Good Manufacturing Practices (GMP) and ensures that all tablets are produced in a contamination-free environment.
2. Wide Range of Products: From antibiotics and antipyretics to vitamins and anti-allergics, Broad Tab offers a diverse portfolio of pharmaceutical tablets.
3. Regulatory Compliance: The company complies with all Indian pharmaceutical regulations, and its products meet international standards.
4. Innovation in Formulation: Broad Tab focuses on research and development, ensuring innovative and effective formulations.
5. Customer-Centric Approach: The company is dedicated to delivering value through quality products and excellent customer service.
Broad Tab Private Limited is committed to enhancing healthcare through reliable, effective, and affordable pharmaceutical solutions.
| S.NO. | Product Name | Composition: Each film coated tablet contains: | P. Ref. | Units |
|---|---|---|---|---|
| 1 | Aceclofenac, Paracetamol | Aceclofenac | IP | 100mg |
| & Serratiopeptidase Tablets. | Paracetamol | IP | 325mg | |
| Serratiopeptidase | IP | 15mg | ||
| (As enteric coated) | ||||
| (eq. to enzyme activity 30000 Units) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 2 | Pregabalin, Nortriptyline & | Composition: Each film coated tablet contains: | ||
| Mecobalamin Tablets. | Pregabalin | IP | 75mg | |
| Nortriptyline Hydrochloride | IP | |||
| Eq. to Nortriptyline | 10mg | |||
| Mecobalamin | IP | 1500mcg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 3 | Methylcobalamin and | Composition: Each film coated tablet contains: | ||
| Gabapentin Tablets | Methylcobalamin | IP | 1500mcg | |
| Gabapentin | IP | 600mg | ||
| (As sustained release form) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 4 | Calcium citrate, Vitamin D3, | Composition: Each uncoated tablet contains: | ||
| Magnesium Hydroxide and | Calcium citrate | USP | 1000mg | |
| Zinc sulphate Tablets. | Vitamin D3 | IP | 200 IU | |
| Magnesium Hydroxide | IP | 100mg | ||
| Zinc sulphate monohydrate | IP | 4mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Composition: Each film coated tablet contains: | P. Ref. | Units | ||
| 5 | Calcium and Vitamin D3 Tablets. IP | Calcium carbonate | IP | 1.250gm |
| (1.25gm of calcium carbonate from an organic source (Oyster shell) eq. to elemental Calcium 500mg) | ||||
| Vitamin D3 | IP | 250 IU | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 6 | Ketorolac Tromethamine | Ketorolac Tromethamine | IP | 10mg |
| Tablets IP | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| 7 | Ivermectin Tablets IP | Composition: Each uncoated dispersible tablet contains: | ||
| Ivermectin | IP | 12mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 8 | Ivermectin Tablets IP | Composition: Each uncoated dispersible tablet contains: | ||
| Ivermectin | IP | 6mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 9 | Esomeprazole Tablets IP | Composition: Each enteric coated tablet contains: | ||
| Esomeprazole Magnesium Trihydrate | IP | |||
| Eq. to Esomeprazole | 40mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| 10 | Esomeprazole Tablets IP | Composition: Each enteric coated tablet contains: | ||
| Esomeprazole Magnesium Trihydrate | IP | |||
| Eq. to Esomeprazole | 20mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Fexofenadine Hydrochloride | Composition: Each film coated tablet contains: | |||
| Tablets IP | Fexofenadine Hydrochloride | IP | 120mg | |
| 11 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Fexofenadine Hydrochloride | Composition: Each film coated tablet contains: | |||
| Tablets IP | Fexofenadine Hydrochloride | IP | 180mg | |
| 12 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Febuxostat Tablets | Composition: Each film coated tablet contains: | |||
| Febuxostat | 80mg | |||
| 13 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Febuxostat Tablets | Composition: Each film coated tablet contains: | |||
| Febuxostat | 40mg | |||
| 14 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Rifaximin Tablets | Composition: Each film coated tablet contains: | |||
| 15 | Rifaximin | BP | 550mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Methylprednisolone Tablets IP | Composition: Each film coated tablet contains: | |||
| Methylprednisolone | IP | 4mg | ||
| 16 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Methylprednisolone Tablets IP | Composition: Each film coated tablet contains: | |||
| Methylprednisolone | IP | 8mg | ||
| 17 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Methylprednisolone Tablets IP | Composition: Each film coated tablet contains: | |||
| 18 | Methylprednisolone | IP | 16mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Etoricoxib Tablet IP | Composition: Each film coated tablet contains: | |||
| 19 | Etoricoxib | IP | 90mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Etoricoxib Tablet IP | Composition: Each film coated tablet contains: | |||
| 20 | Etoricoxib | 120mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Drotaverine Hydrochloride | Composition: Each film coated tablet contains: | |||
| Tablets IP | Drotaverine Hydrochloride | IP | 80mg | |
| 21 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Levocetirizine Hydrochloride | Composition: Each film coated tablet contains: | |||
| Tablets IP | Levocetirizine Hydrochloride | IP | 5mg | |
| 22 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Fluconazole Tablets IP | Composition: Each uncoated tablet contains: | |||
| Fluconazole | IP | 150mg | ||
| 23 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Fluconazole Tablets IP | Composition: Each uncoated tablet contains: | |||
| 24 | Fluconazole | IP | 200mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Cetirizine Hydrochloride | Composition: Each uncoated tablet contains: | |||
| 25 | Tablets IP | Cetirizine Hydrochloride | IP | 10mg |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Terbinafine Tablets IP | Composition: Each uncoated tablet contains: | |||
| Terbinafine Hydrochloride | IP | |||
| 26 | Eq. to Terbinafine | 250mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Etizolam Tablets IP | Composition: Each uncoated tablet contains: | |||
| 27 | Etizolam | IP | 0.25mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ursodeoxycholic acid Tablets IP | Composition: Each film coated tablet contains: | |||
| 28 | Ursodeoxycholic acid | IP | 150mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ursodeoxycholic acid Tablets IP | Composition: Each film coated tablet contains: | |||
| 29 | Ursodeoxycholic acid | IP | 300mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Albendazole Tablets IP | Composition: Each uncoated tablet contains: | |||
| 30 | Albendazole | IP | 400mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Terbinafine Tablets IP | Composition: Each uncoated tablet contains: | |||
| 31 | Terbinafine Hydrochloride | IP | 250mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Rabeprazole & Domperidone | Composition: Each enteric coated tablet contains: | |||
| 32 | Tablets | Rabeprazole sodium | IP | 20mg |
| Domperidone | IP | 10mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Pantoprazole & Domperidone | Composition: Each enteric coated tablet contains: | |||
| Tablets | Pantoprazole sodium sesquehydrate | IP | ||
| Eq. to Pantoprazole | 40mg | |||
| 33 | Domperidone | IP | 10mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Serratiopeptidase and Diclofenac | Composition: Each enteric coated tablet contains: | |||
| Sodium Tablets | Diclofenac Sodium | IP | 50mg | |
| Serratiopeptidase | IP | 10mg | ||
| 34 | (eq. to enzymatic activity 20000 Units) | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ornidazole and Levofloxacin | Composition: Each film coated tablet contains: | |||
| Tablets | Ornidazole | IP | 500mg | |
| 35 | Levofloxacin Hemihydrate | IP | ||
| Eq. to Levofloxacin | 250mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Mefenamic acid & Dicyclomine | Composition: Each uncoated tablet contains: | |||
| 36 | Hydrochloride Tablets IP | Mefenamic acid | IP | 250mg |
| Dicyclomine Hydrochloride | IP | 80mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Amlodipine & Metoprolol | Composition: Each film coated tablet contains: | |||
| Succinate Tablets | Amlodipine Besylate | IP | ||
| eq. to Amlodipine | 5mg | |||
| 37 | Metoprolol Succinate | IP | ||
| Eq. to Metoprolol Tartrate | 50mg | |||
| (As extended Release) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Gabapentin & Nortriptyline | Composition: Each film coated tablet contains: | |||
| Hydrochloride Tablets | Gabapentin | IP | 400mg | |
| 38 | Nortriptyline Hydrochloride | IP | ||
| Eq. to Nortriptyline | 10mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Loprnoxicam & Paracetamol | Composition: Each film coated tablet contains: | |||
| Tablets | Loprnoxicam | 8mg | ||
| 39 | Paracetamol | IP | 325mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Etodolac & Thiocolchicoside | Composition: Each film coated tablet contains: | |||
| 40 | Tablets | Etodolac | IP | 60mg |
| Thiocolchicoside | IP | 4mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Etodolac & Thiocolchicoside | Composition: Each film coated tablet contains: | |||
| 45 | Tablets | Etodolac | IP | 400mg |
| Thiocolchicoside | IP | 4mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Glucosamine, Diacerein and | Composition: Each film coated tablet contains: | |||
| Methylsulfonylmethane Tablets | Glucosamine sulfate potassium chloride | USP | 750mg | |
| 46 | Diacerein | IP | 50mg | |
| Methylsulfonylmethane | USP | 250mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Tranexamic acid & Mefenamic | Composition: Each film coated tablet contains: | |||
| Acid Tablets | Tranexamic acid | IP | 500mg | |
| 47 | Mefenamic acid | IP | 250mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Montelukast sodium and | Composition: Each film coated tablet contains: | |||
| Levocetirizine HCl Tablets | Montelukast sodium | IP | ||
| 48 | Eq. to Montelukast | 10mg | ||
| Levocetirizine Dihydrochloride | IP | 5mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Aceclofenac, Paracetamol and | Composition: Each film coated tablet contains: | |||
| Thiocolchicoside Tablets | Aceclofenac | IP | 100mg | |
| 49 | Paracetamol | IP | 325mg | |
| Thiocolchicoside | IP | 4mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Citicolin & Piracetam Tablets | Composition: Each film coated tablet contains: | |||
| Citicolin Sodium | IP | |||
| 50 | Eq. to Citicolin | 500mg | ||
| Piracetam | IP | 800mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Montelukast sodium and | Composition: Each film coated tablet contains: | |||
| Fexofenadine HCl Tablets | Montelukast sodium | IP | ||
| 51 | Eq. to Montelukast | 10mg | ||
| Fexofenadine hydrochloride | IP | 120mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (SR), | Composition: Each uncoated bilayered tablet contains: | |||
| Glimepiride & Voglibose | Metformin Hydrochloride | IP | 500mg | |
| Tablets | (As Sustained Release Form) | |||
| 52 | Glimepiride | IP | 1mg | |
| Voglibose | IP | 0.2mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (SR), | Composition: Each uncoated bilayered tablet contains: | |||
| Glimepiride & Voglibose | Metformin Hydrochloride | IP | 500mg | |
| 53 | Tablets | (As Sustained Release) | ||
| Glimepiride | IP | 1mg | ||
| Voglibose | IP | 0.3mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol and Diclofenac | Composition: Each uncoated tablet contains: | |||
| Potassium Tablets | Paracetamol | IP | 325mg | |
| 54 | Diclofenac Potassium | BP | 50mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Montelukast sodium, Ambroxol | Composition: Each uncoated bilayered tablet contains: | |||
| HCl (SR) & Levocetirizine HCl | Montelukast sodium | IP | ||
| Tablets | Eq. to Montelukast | 10mg | ||
| Levocetirizine Dihydrochloride | IP | 5mg | ||
| 55 | Ambroxol Hydrochloride | IP | 75mg | |
| (As Sustained Release) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (ER), | Composition: Each uncoated tablet contains: | |||
| Glimepiride & Pioglitazone HCl | Metformin Hydrochloride | IP | 500mg | |
| Tablets | (As Extended Release) | |||
| 56 | Glimepiride | IP | 1mg | |
| Pioglitazone Hydrochloride | IP | |||
| Eq. to Pioglitazone | 15mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Albendazole & Ivermectin Tab. | Composition: Each uncoated tablet contains: | |||
| Albendazole | IP | 400mg | ||
| 57 | Ivermectin | IP | 6mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (SR), | Composition: Each uncoated bilayered tablet contains: | |||
| Gliclazide (SR) & Pioglitazone HCl Tablets | Metformin Hydrochloride | IP | 500mg | |
| 58 | (As Sustained Release) | |||
| Gliclazide | IP | 30mg | ||
| (As Sustained Release) | ||||
| Pioglitazone Hydrochloride | IP | |||
| Eq. to Pioglitazone | 15mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (PR) | Composition: Each uncoated tablet contains: | |||
| & Glimepiride Tablets IP | Metformin Hydrochloride | IP | 500mg | |
| (As Prolonged Release) | ||||
| 59 | Glimepiride | IP | 2mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (PR) | Composition: Each uncoated tablet contains: | |||
| & Glimepiride Tablets IP | Metformin Hydrochloride | IP | 500mg | |
| (As Prolonged Release) | ||||
| 60 | Glimepiride | IP | 1mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Amlodipine &Atenolol Tablets IP | Composition: Each uncoated tablet contains: | |||
| Amlodipine Besylate | IP | |||
| eq. to Amlodipine | 5mg | |||
| 61 | Atenolol | IP | 50mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Etoricoxib & Paracetamol Tab. | Composition: Each uncoated tablet contains: | |||
| Etoricoxib | IP | 60mg | ||
| 62 | Paracetamol | IP | 325mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Tramadol HCl, Paracetamol & | Composition: Each uncoated tablet contains: | |||
| Domperidone Tablets | Tramadol Hydrochloride | IP | 50mg | |
| 63 | Paracetamol | IP | 325mg | |
| Domperidone | IP | 15mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Cetirizine hydrochloride, | Composition: Each uncoated tablet contains: | |||
| Phenylephrine hydrochloride & | Cetirizine hydrochloride | IP | 5mg | |
| 64 | Paracetamol Tablets | Phenylephrine hydrochloride | IP | 5mg |
| Paracetamol | IP | 500mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Aceclofenac, Paracetamol & | Composition: Each film-coated tablet contains: | |||
| Trypsin-Chymotrypsin Tablets | Paracetamol | IP | 325mg | |
| 65 | Aceclofenac | IP | 100mg | |
| Trypsin-Chymotrypsin | 50000 AU | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Deflazacort Tablets | Composition: Each uncoated tablet contains: | |||
| Deflazacort | 6mg | |||
| 66 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Deflazacort Tablets | Composition: Each uncoated tablet contains: | |||
| 67 | Deflazacort | 30mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Deflazacort Tablets | Composition: Each uncoated tablet contains: | |||
| Deflazacort | 12mg | |||
| 68 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Pantoprazole & Domperidone | Composition: Each enteric-coated tablet contains: | |||
| Tablets | Pantoprazole sodium sesquehydrate | IP | ||
| 69 | Eq. to Pantoprazole | 40mg | ||
| Domperidone | IP | 10mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Rabeprazole & Domperidone | Composition: Each enteric-coated tablet contains: | |||
| 70 | Tablets | Rabeprazole Sodium | IP | 20mg |
| Domperidone | IP | 10mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Aceclofenac & Thiocolchicoside | Composition: Each film-coated tablet contains: | |||
| Tablets | Aceclofenac | IP | 100mg | |
| 71 | Thiocolchicoside | IP | 4mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol Tablets IP 650mg | Composition: Each uncoated tablet contains: | |||
| Paracetamol | IP | 650mg | ||
| 72 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| L-Carnitine L-Tatrate, Folic acid | Composition: Each film-coated tablet contains: | |||
| & Methylcobalamin Tablets | L-Carnitine L-Tatrate | 500mg | ||
| 73 | Folic acid | IP | 1.5mg | |
| Methylcobalamin | IP | 1500mcg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Gabapentin & Methylcobalamin | Composition: Each film-coated tablet contains: | |||
| Tablets | Gabapentin | IP | 300mg | |
| 74 | Methylcobalamin | IP | 500mcg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol, Phenylephrine HCl, | Composition: Each un-coated tablet contains: | |||
| Caffeine anhydrous and | Paracetamol | IP | 500mg | |
| Diphenhydramine HCl Tablets | Caffeine anhydrous | IP | 30mg | |
| 75 | Phenylephrine Hydrochloride | IP | 5mg | |
| Diphenhydramine Hydrochloride | IP | 25mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Doxylamine Succinate, Pyridoxine HCl & Folic acid Tablets | Composition: Each enteric coated tablet contains: | |||
| Doxylamine Succinate | USP | 10mg | ||
| Pyridoxine HCl | IP | 10mg | ||
| 76 | Folic acid | IP | 2.5mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Pancreatin & Activated | Composition: Each enteric coated tablet contains: | |||
| 77 | Dimethicone Tablets | Pancreatin | IP | 170mg |
| Activated Dimethicone | IP | 80mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol, Diclofenac | Composition: Each film coated tablet contains: | |||
| potassium & Serratiopeptidase | Paracetamol | IP | 325mg | |
| Tablets | Diclofenac potassium | IP | 50mg | |
| 78 | Serratiopeptidase | IP | 10mg | |
| (eq. to 20000 enzymatic Units) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Atorvastatin Tablets IP | Composition: Each film coated tablet contains: | |||
| Atorvastatin calcium | IP | |||
| 79 | eq. to Atorvastatin | 40mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol, Diclofenac sodium and Serratiopeptidase Tablets | Composition: Each film-coated tablet contains: | |||
| Paracetamol | IP | 325mg | ||
| Diclofenac Sodium | IP | 50mg | ||
| 80 | Serratiopeptidase | IP | 15mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Hydroxychloroquine sulphate | Composition: Each film-coated tablet contains: | |||
| Tablets IP | Hydroxychloroquine sulphate | IP | 300mg | |
| 81 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Azithromycin & Lactic acid | Composition: Each film-coated tablet contains: | |||
| Bacillus Tablets | Azithromycin Dihydrate | IP | ||
| 82 | eq. to Azithromycin | 500mg | ||
| Lactic acid bacillus | 60 million spo | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ofloxacin & Ornidazole Tablet IP | Composition: Each film-coated tablet contains: | |||
| Ofloxacin | IP | 200mg | ||
| 83 | Ornidazole | IP | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ofloxacin, Ornidazole & Lactic | Composition: Each film-coated tablet contains: | |||
| Acid bacillus Tablets | Ofloxacin | IP | 200mg | |
| 84 | Ornidazole | IP | 500mg | |
| Lactic acid bacillus | 5 billion spore | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Tadalafil Tablets IP | Composition: Each film-coated tablet contains: | |||
| 85 | Tadalafil | IP | 5mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Levofloxacin & Ornidazole | Composition: Each film-coated tablet contains: | |||
| Tablets | Levofloxacin Hemihydrate | IP | ||
| 86 | eq. to Levofloxacin | 250mg | ||
| Ornidazole | IP | 500mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Cilnidipine Tablets IP | Composition: Each film-coated tablet contains: | |||
| 87 | Cilnidipine | IP | 10mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Gabapentin Tablets IP | Composition: Each film-coated tablet contains: | |||
| 88 | Gabapentin | IP | 300mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Calcium citrate, Methylcobalamin, | Composition: Each film-coated tablet contains: | |||
| Vit-D3, L-Methylfolate & | Calcium citrate | USP | 1250mg | |
| Pyridoxal-5-Phosphate Tablets | Vitamin-D3 | IP | 2000 IU | |
| 89 | Methylcobalamin | IP | 1500mcg | |
| L-Methylfolate | 1mg | |||
| Pyridoxal-5-Phosphate | 20mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Calcium citrate, Calcitriol & | Composition: Each film-coated tablet contains: | |||
| Vitamin K2-7 Tablets | Calcium citrate | USP | 1200mg | |
| 90 | Vitamin K2-7 | 50mcg | ||
| Calcitriol | IP | 0.25mcg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Piracetam Tablets | Composition: Each film-coated tablet contains: | |||
| 91 | Piracetam | IP | 800mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Levocetirizine Dihydrochloride | Composition: Each film-coated tablet contains: | |||
| 92 | & Ambroxol HCl Tablets | Levocetirizine Dihydrochloride | IP | 5mg |
| Ambroxol Hydrochloride | IP | 30mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ciprofloxacin Tablets IP | Composition: Each film-coated tablet contains: | |||
| 93 | Ciprofloxacin Hydrochloride | IP | ||
| eq. to Ciprofloxacin | 500mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol, Aceclofenac & | Composition: Each Un-coated tablet contains: | |||
| 94 | Chlorzoxazone Tablets | Paracetamol | IP | 325mg |
| Aceclofenac | IP | 100mg | ||
| Chlorzoxazone | USP | 250mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Atorvastatin Tablets IP | Composition: Each film coated tablet contains: | |||
| Atorvastatin calcium | IP | |||
| 95 | eq. to Atorvastatin | 10mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| S-Adenosyl-L-Methionine | Composition: Each enteric coated tablet contains: | |||
| 96 | Disulfate Tablets | S-Adenosyl-L-Methionine Disulfate | 400mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Aspirin Tablets IP | Composition: Each Un-coated tablet contains: | |||
| 97 | Aspirin | IP | 300mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol, Diclofenac Sodium | Composition: Each Un-coated tablet contains: | |||
| & Chlorzoxazone Tablets | Paracetamol | IP | 325mg | |
| 98 | Diclofenac Sodium | IP | 50mg | |
| Chlorzoxazone | USP | 500mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol & Nimesulide | Composition: Each Un-coated tablet contains: | |||
| Tablets | Paracetamol | IP | 325mg | |
| 99 | Nimesulide | BP | 100mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Gabapentin, Methylcobalamin | Composition: Each film coated tablet contains: | |||
| & Alpha Lipoic Acid Tablets | Gabapentin | IP | 100mg | |
| 100 | Methylcobalamin | IP | 500mcg | |
| Alpha Lipoic Acid | IP | 100mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Flunarizine & Domperidone | Composition: Each Un-coated tablet contains: | |||
| Tablets | Flunarizine Dihydrochloride | IP | ||
| 101 | eq. Flunarizine | 5mg | ||
| Domperidone | IP | 10mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Aceclofenac & Paracetamol | Composition: Each film coated tablet contains: | |||
| Tablets | Aceclofenac | IP | 100mg | |
| 102 | Paracetamol | IP | 325mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol & Domperidone | Composition: Each Un-coated tablet contains: | |||
| Tablets | Paracetamol | IP | 650mg | |
| 103 | Domperidone | IP | 20mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin HCl (ER), | Each Un-coated bilayered tablet contains: | |||
| Glimepiride & Voglibose Tablets | Metformin Hydrochloride | IP | 500mg | |
| 104 | (As extended release form) | |||
| Glimepiride | IP | 2mg | ||
| Voglibose | IP | 0.2mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Fexofenadine HCl, Montelukast | Each Un-coated bilayered tablet contains: | |||
| Sodium & Acebrophylline (SR) | Fexofenadine Hydrochloride | IP | 120mg | |
| 105 | Tablets | Montelukast Sodium | IP | |
| Eq. to Montelukast | 10mg | |||
| Acebrophylline | 200mg | |||
| (As Sustained Release form) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Nimesulide, Phenylephrine HCl, | Composition: Each Un-coated tablet contains: | |||
| Cetirizine HCl & Caffeine Tab. | Nimesulide | BP | 100mg | |
| 106 | Phenylephrine Hydrochloride | IP | 10mg | |
| Cetirizine Hydrochloride | IP | 5mg | ||
| Caffeine | IP | 30mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Nimesulide, Phenylephrine HCl, | Composition: Each Un-coated tablet contains: | |||
| Paracetamol & Caffeine Tab. | Paracetamol | IP | 325mg | |
| 107 | Nimesulide | BP | 100mg | |
| Phenylephrine Hydrochloride | IP | 10mg | ||
| Caffeine | IP | 25mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol, Phenylephrine HCl, | Composition: Each Un-coated tablet contains: | |||
| Cetirizine HCl, Guaiphenesin & | Paracetamol | IP | 325mg | |
| Ambroxol HCl Tablets | Phenylephrine Hydrochloride | IP | 5mg | |
| 108 | Cetirizine Hydrochloride | IP | 5mg | |
| Guaiphenesin | IP | 50mg | ||
| Ambroxol Hydrochloride | IP | 15mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Albendazole & Ivermectin Tab. | Composition: Each film coated tablet contains: | |||
| Albendazole | IP | 400mg | ||
| 109 | Ivermectin | IP | 6mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Fluconazole Dispersible Tablets | Each un-coated dispersible tablet contains: | |||
| 110 | Fluconazole | IP | 50mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Pioglitazone HCl & Glimepiride | Composition: Each film coated tablet contains: | |||
| Tablets | Pioglitazone Hydrochloride | IP | ||
| 111 | eq. to Pioglitazone | 15mg | ||
| Glimepiride | IP | 2mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Drotaverine HCl & Paracetamol | Composition: Each uncoated tablet contains: | |||
| Tablets | Drotaverine Hydrochloride | IP | 80mg | |
| 112 | Paracetamol | IP | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Tadalafil Tablets IP | Composition: Each film coated tablet contains: | |||
| 113 | Tadalafil | IP | 10mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ciprofloxacin & Ornidazole | Composition: Each film coated tablet contains: | |||
| Tablets | Ciprofloxacin Hydrochloride | IP | ||
| 114 | eq. to Ciprofloxacin | 500mg | ||
| Ornidazole | IP | 500mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Calcium carbonate & Vitamin | Composition: Each film coated tablet contains: | |||
| D3 Tablets IP | Calcium carbonate | IP | ||
| 114 | eq. to elemental Calcium | 500mg | ||
| Vitamin D3 | IP | 200 IU | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Coral Calcium, Cholecalciferol | Composition: Each film coated tablet contains: | |||
| & Vitamin K2-7 Tablets | Coral Calcium | IP | ||
| eq. to elemental Calcium | 500mg | |||
| 114 | Cholecalciferol | IP | 1000 IU | |
| Vitamin K2-7 | 50mcg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Thiocolchicoside Sustained | Composition: Each uncoated (SR) tablet contains: | |||
| 115 | Release Tablets | Thiocolchicoside | IP | 16mg |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Paracetamol Tablets IP | Composition: Each uncoated tablet contains: | |||
| 116 | Paracetamol | IP | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Diacerein & Aceclofenac Tablet | Composition: Each film coated tablet contains: | |||
| Diacerein | IP | 50mg | ||
| 117 | Aceclofenac | IP | 100mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin HCl (ER) & | Composition: Each film coated tablet contains: | |||
| Saxagliptin Tablets | Metformin Hydrochloride | IP | 500mg | |
| 118 | (As extended release form) | |||
| Saxagliptin Hydrochloride | ||||
| eq. to Saxagliptin | 5mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Rutoside Trihydrate, Bromelain, | Composition: Each enteric coated tablet contains: | |||
| Aceclofenac & Trypsin Tablets | Rutoside Trihydrate | BP | 100mg | |
| 119 | Bromelain | IP | 90mg | |
| Aceclofenac | IP | 100mg | ||
| Trypsin | IP | 48mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Ibuprofen & Chlorzoxazone Tab | Composition: Each uncoated tablet contains: | |||
| Ibuprofen | IP | 400mg | ||
| 120 | Chlorzoxazone | USP | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Moxifloxacin Tablets | Composition: Each film coated tablet contains: | |||
| Moxifloxacin Hydrochloride | IP | |||
| 121 | eq. to Moxifloxacin | 400mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metoprolol Succinate Prolonged | Composition: Each uncoated (PR) tablet contains | |||
| 122 | Release Tablets IP | Metoprolol Succinate | IP | 25mg |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Tofacitinib Tablets IP | Composition: Each film coated tablet contains: | |||
| Tofacitinib Citrate | IP | |||
| 123 | eq. to Tofacitinib | 5mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Mefenamic acid & Dicyclomine | Composition: Each uncoated tablet contains | |||
| Hydrochloride Tablets IP | Mefenamic acid | IP | 250mg | |
| 124 | Dicyclomine Hydrochloride | IP | 20mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Azithromycin & Ambroxol HCl | Composition: Each film coated tablet contains: | |||
| (SR) Tablets | Azithromycin Dihydrate | IP | ||
| eq. to Azithromycin | 500mg | |||
| 125 | Ambroxol Hydrochloride | IP | 75mg | |
| (As Sustained Release form) | ||||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Pyridoxine Hydrochloride (CR) | Composition: Each uncoated (CR) tablet contains | |||
| Tablets | Pyridoxine Hydrochloride | IP | 100mg | |
| 126 | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Oral (Rehydration salt) Tablets | Composition: Each uncoated tablet contains | |||
| Sodium Chloride | IP | 0.125gm | ||
| Potassium Chloride | IP | 0.150gm | ||
| 127 | Sodium Bicarbonate | IP | 0.250gm | |
| Citric acid (Anhydrous) | IP | 0.577gm | ||
| Dextrose (Anhydrous) | IP | 2.650gm | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Telmisartan & Amlodipine | Composition: Each uncoated tablet contains | |||
| Tablets IP | Telmisartan | IP | 40mg | |
| 128 | Amlodipine Besylate | IP | ||
| eq. to Amlodipine | 5mg | |||
| Excipients | q.s | |||
| Vitamin D3 Chewable Tablets | Each uncoated chewable tablet contains | |||
| 129 | Vitamin D3 | IP | 60000 IU | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Metformin Hydrochloride (ER), | Each uncoated bilayered tablet contains | |||
| Glimepiride & Pioglitazone | Metformin Hydrochloride | IP | 500mg | |
| Tablets | (As extended release form) | |||
| 130 | Glimepiride | IP | 1mg | |
| Pioglitazone Hydrochloride | IP | |||
| eq. to Pioglitazone | 15mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| LEVOCETIRIZINE HYDROCHLORIDE | IP | 5MG | ||
| 131 | LEVOCETIRIZINE HCI & AMBROXOL | Ambroxol Hydrochloride | IP | 60MG |
| HCI TABLETS | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Gabapentin | IP | 100mg | ||
| 132 | Gabapentin & Methylcobalamin | Methylcobalamin | IP | 500mcg |
| TABLETS | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Sildenafil Citrate | IP | 100mg | ||
| 133 | Sildenafil Citrate Tablets IP | eq. to Sildenafil | q.s | |
| Excipients | ||||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Sildenafil Citrate | IP | 50mg | ||
| 134 | Sildenafil Citrate Tablets IP | eq. to Sildenafil | q.s | |
| Excipients | ||||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Sildenafil Citrate | IP | |||
| 135 | Sildenafil Citrate Dapoxetine | eq. to Sildenafil | 50mg | |
| Tablets | Dapoxetine Hydrochloride | IP | ||
| eq. to Dapoxetine | 30mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Sildenafil Citrate | IP | |||
| 136 | Sildenafil Citrate Dapoxetine | eq. to Sildenafil | 100mg | |
| Tablets | Dapoxetine Hydrochloride | IP | ||
| eq. to Dapoxetine | 60mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Pyridoxin Hydrochloride | IP | 3mg | ||
| Methylcobalamin Pyridoxin Hcl. | Methylcobalamin | IP | 1500mcg | |
| 137 | Vitamin D3 Folic acid & Alpha | Alpha Lipoic Acid | IP | 100mg |
| Lipoic Acid Tablets | Vitamin D3 | IP | 1000 iu | |
| Folic acid | IP | 1.5mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each uncoated tablet contains | ||||
| Torsemide | IP | 10mg | ||
| 138 | Torsemide Tablets IP | Excipients | q.s | |
| Colour: Approved colour used | ||||
| Each uncoated (MD) tablet contains | ||||
| Lansoprazole | IP | 15mg | ||
| 139 | Lansoprazole Mouth Dissolving | Excipients | q.s | |
| Tablets | Colour: Approved colour used | |||
| Each uncoated bilayered tablet contains | ||||
| Doxofylline (sr) & Montelukast | Doxofylline | IP | ||
| Tablets | (As Sustained Release form) | 400mg | ||
| 140 | Montelukast sodium | IP | ||
| eq. to Montelukast | 10mg | |||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Tadalafi | IP | 20mg | ||
| 141 | Tadalafil & Dapoxetine | eq. to Dapoxetine | IP | 30mg |
| Tablets | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Hydralazine Hydrochloride | IP | 25mg | ||
| 142 | Hydralazine Hydrochloride | Excipients | q.s | |
| Tablets usp | Colour: Approved colour used | |||
| Each film coated tablet contains | ||||
| Tadalafil | IP | 20MG | ||
| 143 | Tadalafil tablets IP | Excipients | q.s | |
| Each film coated tablet contains | ||||
| Paracetamol | IP | 650MG | ||
| 144 | Paracetamol Tablets IP | Excipients | q.s | |
| Each uncoated tablet contains | ||||
| Amlodipine | IP | |||
| 145 | Amlodipine & Indapamide (SR) | eq. to Amlodipine | 10mg | |
| Tablets | Indapamide | IP | 1.5mg | |
| (As sustatned release form) | q.s | |||
| Excipients | ||||
| Each enteric coated tablet contains | ||||
| Pancreatin,Bile Constituents | Pancreatin | IP | 192mg | |
| 146 | & Activated Dimethicone Tablets | Bile Constituents | 25mg | |
| Activated Dimethicone | IP | 40mg | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each uncoated bilayered tablet contains | ||||
| Mefenamic acid | IP | 250mg | ||
| 147 | Mefenamic acid & Dicyclomine | Dicyclomine Hydrochloride | IP | 10mg |
| Hydrochloride Tablets IP | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Each enteric coated tablet contains | ||||
| Ademetionine 1.4-butane disulfonate (SD4) | IP | 400mg | ||
| 148 | Ademetionine Tablets | eq. to Amlodipine Ione | q.s | |
| Excipients | ||||
| Colour: Approved colour used | ||||
| Each uncoated tablet contains | ||||
| Cinnarizine | IP | 20mg | ||
| 149 | Cinnarizine & Dimenhydrinate | Dimenhydrinate | BP | 40mg |
| Tablets | Excipients | q.s | ||
| Colour: Approved colour used | ||||
| Each uncoated (SR) tablet contains | ||||
| Cinnarizine | IP | 75mg | ||
| 150 | Cinnarizine (SR) Tablets | (As sustatned release form) | ||
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Levofloxacin Hemihydrate | IP | |||
| 151 | Levofloxacin tablets IP | eq. to Levofloxacin | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Clopidogrel Bisulphate | IP | |||
| 152 | Clopidogrel tablets IP | eq. to Clopidogrel | 75mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each uncoated tablet contains | ||||
| Cyproheptadine Hydrochloride | IP | |||
| 153 | Cyproheptadine Tablets IP | eq. to Cyproheptadine HCL (Anhydrous) | 4mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each Gastro-Resistant tablet contains | ||||
| Diclofenac Sodium Gastro-Resistant | Diclofenac Sodium | IP | 50mg | |
| 154 | Tablets IP | Excipients | q.s | |
| Colour: Approved colour used | ||||
| Each uncoated tablet contains | ||||
| Dexamethasone | IP | 4mg | ||
| 155 | Dexamethasone Tablets | Excipients | q.s | |
| Colour: Approved colour used | ||||
| Each Prolonged-Release tablet contains | ||||
| Divalproex Sodium | IP | |||
| 156 | Divalproex (PR) Tablets IP | eq. to Divalproex | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each uncoated (MD) tablet contains | ||||
| Dexamethasone | IP | 15MG | ||
| 157 | Lansoprazole Orally (MD) | Excipients | q.s | |
| Disintegrating Tablets | Colour: Approved colour used | |||
| Each uncoated tablet contains | ||||
| Doxofylline | IP | 400MG | ||
| 158 | Doxofylline Tablets IP | Excipients | q.s | |
| Each Gastro-Resistant tablet contains | ||||
| Divalproex Sodium | IP | |||
| 159 | Divalproex (GR) Tablets IP | eq. to Divalproex | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Dried Ferrous Sulphate | IP | 200mg | ||
| 160 | Ferrous Sulphate Tablets IP | eq. to elemental Iron | 60mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Aspirin | IP | 400mg | ||
| 161 | Aspirin & Caffeine Tablets IP | Caffeine (Anhydrous) | 30mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Dapoxetine | IP | |||
| 162 | Dapoxetine Tablets IP | eq. to Dapoxetine | 30mg | |
| Excipients | q.s | |||
| Colour: Approved colour used | ||||
| Each film coated tablet contains | ||||
| Citicoline | IP | |||
| 163 | Citicoline Tablets IP | eq. to Citicoline | 500mg | |
| Excipients | q.s | |||
| Colour: Approved colour used |